#coronavirusdrug #coronavirus #avifavir #russia #russiacoronamedicine #авифавир #coronavirusmedicinerussia#coronavirusvaccine #who #economictimes #bbcnews #coronavaccine #corona #abpnews #modi #news24
Russia’s Health Ministry granted a temporary registration certificate to the country’s first Covid-19 medicine, a generic version of the Japanese flu drug Avigan, the country’s wealth fund said in statement.

As the coronavirus continues to spread, upending economies and life around the world, drug companies have been racing to develop treatments and vaccines. Avifavir, developed by a joint venture of the Russian Direct Investment Fund and ChemRar Group, is designed to disrupt the novel coronavirus’s ability to reproduce and has proven effective in clinical trials.

ДОБАВИТЬ КОММЕНТАРИЙ

Ваш адрес email не будет опубликован. Обязательные поля помечены *